Skip to content

    Niagen Bioscience (NAGE) stock price & financials

    View NAGE earnings calls

    Overview

    Price

    Market Cap

    Sector

    Rank

    Performance66.3% 1Y

    Financials

    Income Statement

    Financial Trajectories

    11
    Quarterly
    MetricQ3 FY24Q4 FY24Q1 FY25Q2 FY25Q3 FY25Q4 FY25Q1 FY26Q2 FY26Trend
    EarningsRevenue
    $25.58M
    $29.13M
    $30.48M
    $31.12M
    $33.99M
    +32.9%
    $33.84M
    +16.2%
    $31.47M
    +3.3%
    $29.79M
    -4.3%
    Strengthening
    Operating Profit
    $1.60M
    $7.11M
    $4.77M
    $3.19M
    $4.24M
    +164.4%
    $4.09M
    -42.5%
    $1.58M
    -67.0%
    $700.0K
    -78.0%
    Weakening
    Net Profit
    $1.88M
    $7.18M
    $5.06M
    $3.61M
    $4.58M
    +143.8%
    $4.13M
    -42.4%
    $6.32M
    +24.8%
    $963.0K
    -73.3%
    Weakening
    EPS
    $0.02
    $0.07
    $0.05
    $0.06
    +200.0%
    $0.08
    +14.3%
    $0.01
    -80.0%
    Weakening
    Other Income
    Interest
    Depreciation
    Profit before Tax
    $1.88M
    $7.48M
    $5.23M
    $3.74M
    $4.80M
    +155.6%
    $4.42M
    -40.9%
    $6.74M
    +28.8%
    $1.07M
    -71.4%
    Weakening
    MarginsOPM
    6.3%
    24.4%
    15.7%
    10.2%
    12.5%
    +99.0%
    12.1%
    -50.6%
    5.0%
    -68.0%
    2.4%
    -77.1%
    Weakening
    Tax
    0.0%
    4.1%
    3.2%
    3.4%
    4.6%
    6.6%
    +61.8%
    6.2%
    +92.8%
    9.9%
    +189.2%
    Strengthening
    ReturnsROIC
    -1.2%
    -4.6%
    -3.2%
    -2.3%
    -2.9%
    -143.8%
    -2.6%
    +42.4%
    -4.0%
    -24.8%
    -0.6%
    +73.3%
    Strengthening

    Balance Sheet

    Balance Sheet

    USD · Annual
    Line itemFY18FY19FY20FY21FY22FY23FY24FY25TTM
    AssetsCash & Equivalents$22.62M$18.81M$16.70M$28.22M$20.30M$27.20M$44.50M$64.79M$66.74M
    Short-Term Investments
    Total Current Assets$36.53M$33.52M$32.22M$48.91M$46.57M$49.53M$64.10M$96.81M$97.79M
    Net PP&E$3.58M$4.66M$4.43M$7.36M$6.32M$4.54M$3.45M$3.52M$3.09M
    Goodwill
    Intangibles$1.55M$1.31M$1.08M$857.0K$671.0K$510.0K$359.0K$5.66M$5.31M
    Total Assets$42.23M$40.25M$38.36M$57.84M$54.06M$54.96M$68.28M$106.41M$106.59M
    LiabilitiesTotal Current Liabilities$14.44M$15.06M$16.48M$17.61M$17.87M$20.62M$17.95M$19.92M$15.05M
    Short-Term Debt
    Long-Term Debt
    Long-Term Leases$0$848.0K$997.0K$4.15M$3.54M$2.56M$1.66M$1.81M$1.41M
    Total Liabilities$15.05M$19.80M$21.93M$26.11M$25.39M$26.51M$22.18M$29.87M$24.06M
    EquityCommon Stock & APIC$55.0K$60.0K$62.0K$68.0K$74.0K$75.0K$77.0K$79.0K$79.0K
    Retained Earnings-$89.75M-$121.90M-$141.82M-$168.95M-$185.49M-$190.46M-$181.91M-$164.53M-$157.25M
    Total Equity$27.18M$20.45M$16.42M$31.73M$28.67M$28.46M$46.09M$76.53M$82.53M
    HighlightsNet Cash / (Debt)

    Cash Flow

    Cash Flow

    USD · Annual
    Line itemFY18FY19FY20FY21FY22FY23FY24FY25TTM
    ActivitiesCash from Operating-$20.91M-$20.44M-$10.60M-$24.16M-$15.10M$7.12M$12.11M$13.50M$5.95M
    Cash from Investing-$1.77M-$249.0K-$165.0K-$409.0K-$334.0K-$143.0K-$143.0K-$292.0K$5.03M
    Cash from Financing-$90.0K$16.88M$8.65M$36.09M$7.65M-$90.0K$5.37M$6.92M-$4.71M
    SummaryCapital Expenditure-$1.32M-$743.0K
    Free Cash Flow-$22.23M-$21.18M
    FCF Margin-70.4%-45.8%

    Ratios